Medication name: * Tri Bedoyecta Comparable patent medicine: Bedoyecta * Tri Active ingredient: hydroxocobalamin (vitamin B12), Thiamine (Vit B1), Pyridoxine (Vit B6) Presentation: Solution for Injection Concentration: 10.000 mg/100 mg/50 mg Extended-release tablets: No Lab: Grossman, S
Vinelli V, Biscotti P, Martini D, Del Bo C, Marino M, Meroo T, et al
Eur J Public Health 30:ckaa166--1147 Bouguerra G, Talbi K, Trabelsi N et al (2021) Enhanced eryptosis in glucose-6-Phosphate dehydrogenase deficiency
A blood test that analysis certain antibodies such as pANCA might be assessed, or general inflammatory markers such as CRP
They believed it differed from pancreozymin, another small intestine hormone identified by Ivy in 1928 that was subsequently renamed cholecystokinin (CCK) (Kosaka, Lim)